BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16264933)

  • 1. Does addition of temozolomide to whole brain radiotherapy improve outcome in patients with brain metastases?
    Erridge SC; Gregor A
    Nat Clin Pract Oncol; 2005 Apr; 2(4):194-5. PubMed ID: 16264933
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of temozolomide and concomitant whole-brain radiotherapy in patients with brain metastases from solid tumors.
    Kouvaris JR; Miliadou A; Kouloulias VE; Kolokouris D; Balafouta MJ; Papacharalampous XN; Vlahos LJ
    Onkologie; 2007 Jul; 30(7):361-6. PubMed ID: 17596744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemotherapy for brain metastasis: how to define a role for temozolomide.
    Weller M
    Onkologie; 2007 Jul; 30(7):350-1. PubMed ID: 17596741
    [No Abstract]   [Full Text] [Related]  

  • 4. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial.
    Verger E; Gil M; Yaya R; Viñolas N; Villà S; Pujol T; Quintó L; Graus F
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):185-91. PubMed ID: 15629610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
    Hamilton DA
    Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of brain metastases from melanoma.
    Legha SS
    J Clin Oncol; 2005 May; 23(13):3155; author reply 3155-6. PubMed ID: 15860880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 8. Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation?
    Boogerd W; de Gast GC; Dalesio O
    Cancer; 2007 Jan; 109(2):306-12. PubMed ID: 17149755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases.
    Antonadou D; Paraskevaidis M; Sarris G; Coliarakis N; Economou I; Karageorgis P; Throuvalas N
    J Clin Oncol; 2002 Sep; 20(17):3644-50. PubMed ID: 12202665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic radiotherapy for glioblastoma in the elderly.
    Tartarone A; Ardito R; Romano C
    N Engl J Med; 2007 Jul; 357(2):196; author reply 196. PubMed ID: 17626310
    [No Abstract]   [Full Text] [Related]  

  • 11. Promises and controversies in the management of low-grade glioma.
    Stupp R; Baumert BG
    Ann Oncol; 2003 Dec; 14(12):1695-6. PubMed ID: 14630671
    [No Abstract]   [Full Text] [Related]  

  • 12. Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases.
    Hofmann M; Kiecker F; Wurm R; Schlenger L; Budach V; Sterry W; Trefzer U
    J Neurooncol; 2006 Jan; 76(1):59-64. PubMed ID: 16132502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome.
    Panagiotou IE; Brountzos EN; Kelekis DA; Papathanasiou MA; Bafaloukos DI
    Neoplasma; 2005; 52(2):150-8. PubMed ID: 15800714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future developments in the use of temozolomide for the treatment of brain tumours.
    Stupp R; Gander M; Leyvraz S; Newlands E
    Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.
    Dufour C; Da Costa L; Auger N; Jullien M; Bhangoo R; Grill J
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):857-9. PubMed ID: 18989164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis.
    Zhao Q; Qin Q; Sun J; Han D; Wang Z; Teng J; Li B
    PLoS One; 2016; 11(3):e0150419. PubMed ID: 26930609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of brain metastases of malignant melanoma with temozolomide.
    Biasco G; Pantaleo MA; Casadei S
    N Engl J Med; 2001 Aug; 345(8):621-2. PubMed ID: 11529230
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effectiveness of whole-brain radiotherapy plus temozolomide versus whole-brain radiotherapy in treating brain metastases based on a systematic review of randomized controlled trials.
    Bai GR; An JB; Chu Y; Wang XY; Li SM; Yan KJ; Lü FR; Gu N; Griffin AN; Sun BY; Li W; Wang GC; Zhou SP; Sun H; Liu CX
    Anticancer Drugs; 2016 Jan; 27(1):1-8. PubMed ID: 26426520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy in high-grade gliomas.
    Ulutin C
    Tumori; 2007; 93(5):526; author reply 526. PubMed ID: 18038893
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiotherapy for metastatic brain tumors.
    Shibamoto Y; Sugie C; Iwata H
    Int J Clin Oncol; 2009 Aug; 14(4):281-8. PubMed ID: 19705237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.